APA

Mesa R. A., Miller C. B., Thyne M., Mangan J., Goldberger S., Fazal S., Ma X., Wilson W., Paranagama D. C., Dubinski D. G., Naim A., Parasuraman S., Boyle J. & Mascarenhas J. O. (20170601). Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark survey. : Cancer.

Chicago

Mesa Ruben A, Miller Carole B, Thyne Maureen, Mangan James, Goldberger Sara, Fazal Salman, Ma Xiaomei, Wilson Wendy, Paranagama Dilan C, Dubinski David G, Naim Ahmad, Parasuraman Shreekant, Boyle John and Mascarenhas John O. 20170601. Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark survey. : Cancer.

Harvard

Mesa R. A., Miller C. B., Thyne M., Mangan J., Goldberger S., Fazal S., Ma X., Wilson W., Paranagama D. C., Dubinski D. G., Naim A., Parasuraman S., Boyle J. and Mascarenhas J. O. (20170601). Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark survey. : Cancer.

MLA

Mesa Ruben A, Miller Carole B, Thyne Maureen, Mangan James, Goldberger Sara, Fazal Salman, Ma Xiaomei, Wilson Wendy, Paranagama Dilan C, Dubinski David G, Naim Ahmad, Parasuraman Shreekant, Boyle John and Mascarenhas John O. Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark survey. : Cancer. 20170601.